Aktie NSTM NOVELSTEM
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NOVELSTEM OTC Markets

Aktien

NSTM

US4362331005

NSTM

Verzögert OTC Markets
Andere Börsenplätze
 16:59:07 05.10.2021 		% 5 Tage % 1. Jan.
0.27 USD +7.57% Intraday Chart für NOVELSTEM -3.50% +44.75%
01.04. NovelStem International Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 NovelStem International Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
NovelStem International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
NovelStem International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
NovelStem International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
NOVELSTEM INTERNATIONAL CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Novelstem International Corp. Appoints Jan Loeb as President
NOVELSTEM INTERNATIONAL CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers (form 8-K)
NovelStem International Corp. Elects Christine Jenkins as Chief Financial Officer
NovelStem International Corp. Elects Jan Loeb as Principal Executive Officer
NovelStem International Corp. Announces Management Changes
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares
NovelStem International Corp and Newstem Ltd. Announce New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and Covid-19 Resistance
NovelStem International Corp.'s Equity Buyback announced on January 16, 2018, has expired.
Hollywood Media Corp. will Change its Ticker to NSTM from HOLL
Hollywood Media Corp. has Changed its Name to NovelStem International Corp
Hollywood Media Corp. Announces Board Changes
NewStem Ltd. announced that it expects to receive $4 million in funding from Hollywood Media Corp.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2N6SQ Aktie
  4. NSTM Aktie
  5. Nachrichten NOVELSTEM
  6. Andere Sprachen